Antiangiogenic and antitumor potential of berbamine, a natural CaMKIIγ inhibitor, against glioblastoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiangiogenic and antitumor potential of berbamine, a natural CaMKIIγ inhibitor, against glioblastoma
Authors
Keywords
Glioblastoma, Angiogenesis, Berbamine, VEGF, VEGFR2, BDNF, TrkB, CaMKIIγ
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 566, Issue -, Pages 129-134
Publisher
Elsevier BV
Online
2021-06-11
DOI
10.1016/j.bbrc.2021.06.025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Nargenicin A1 Analog Inhibits Angiogenesis by Downregulating the Endothelial VEGF/VEGFR2 Signaling and Tumoral HIF-1α/VEGF Pathway
- (2020) Jang Mi Han et al. Biomedicines
- A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca2+ /calmodulin-dependent protein kinase II
- (2018) Hee Jeong Shin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting WNT Signaling for Multifaceted Glioblastoma Therapy
- (2017) Matthew McCord et al. Frontiers in Cellular Neuroscience
- A Review of VEGF/VEGFR-Targeted Therapeutics for Recurrent Glioblastoma
- (2017) David A. Reardon et al. Journal of the National Comprehensive Cancer Network
- In vitro and in vivo metabolic activation of berbamine to quinone methide intermediate
- (2016) Yao Sun et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis
- (2016) Y Zhao et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Brain-derived neurotrophic factor promotes angiogenic tube formation through generation of oxidative stress in human vascular endothelial cells
- (2014) T. Usui et al. Acta Physiologica
- Berbamine Enhances the Antineoplastic Activity of Gemcitabine in Pancreatic Cancer Cells by Activating Transforming Growth Factor-β/Smad Signaling
- (2014) Xiaoli Jin et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- In Vitro and in Vivo Antitumor Evaluation of Berbamine for Lung Cancer Treatment
- (2014) Zhi-Bo Hou et al. Asian Pacific Journal of Cancer Prevention
- Delivery of Paclitaxel and Berbamine by Polymeric Carriers to Cure Gastric Cancer
- (2013) Lingjun Zhu et al. ONCOLOGY RESEARCH
- CaMKII , a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine
- (2012) Y. Gu et al. BLOOD
- Berbamine Protects the Heart From Ischemia/Reperfusion Injury by Maintaining Cytosolic Ca2+ Homeostasis and Preventing Calpain Activation
- (2012) Cai-Mei Zhang et al. CIRCULATION JOURNAL
- HIFs, angiogenesis, and cancer
- (2012) Yongzhi Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Signal transduction by vascular endothelial growth factor receptors
- (2011) Sina Koch et al. BIOCHEMICAL JOURNAL
- Brain-Derived Neurotrophic Factor Promotes Tumorigenesis via Induction of Neovascularization: Implication in Hepatocellular Carcinoma
- (2011) C.-T. Lam et al. CLINICAL CANCER RESEARCH
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Berbamine, a novel nuclear factor κB inhibitor, inhibits growth and induces apoptosis in human myeloma cells
- (2009) Yun Liang et al. ACTA PHARMACOLOGICA SINICA
- Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action
- (2009) Shan Wang et al. Molecular Cancer
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started